stockportfolio.pro
Stocks / EXEL vs SNN
EXEL vs SNN
Exelixis, Inc. and Smith & Nephew plc side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
EXEL is the larger company ($13.4B vs $12.9B). On the fundamentals, EXEL grows revenue faster (18.6% vs 5.7%); EXEL earns a higher net margin (33.7% vs 10.1%); EXEL has the stronger return on equity (36.2% vs 11.8%). Full numbers below — the stronger figure on each row is in green.
| Exelixis, Inc. (EXEL) | Smith & Nephew plc (SNN) | |
|---|---|---|
| Market cap | $13.4B | $12.9B |
| Revenue (latest FY) | $2.32B | $6.16B |
| Net income (latest FY) | $782.57M | $625.00M |
| Revenue growth (5y CAGR) | 18.6% | 5.7% |
| Net margin | 33.7% | 10.1% |
| Return on equity | 36.2% | 11.8% |
| P/E ratio | 17.6 | 21.3 |
| Dividend yield | — | 2.5% |
| Profitable years (of last 10) | 9 | 4 |
| Positive free cash flow | Yes | Yes |
Compare with another company:
See the full EXEL vs SNN breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open EXEL's full financials → Open SNN's full financials →More comparisons
Frequently asked questions
Which is bigger, EXEL or SNN?
Exelixis, Inc. is larger by market capitalization — $13.4B versus $12.9B.
Which grows faster, EXEL or SNN?
Over the last five fiscal years, Exelixis, Inc. grew revenue faster — 18.6%/yr versus 5.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.